Land: Australië
Taal: Engels
Bron: Department of Health (Therapeutic Goods Administration)
Irinotecan hydrochloride
Baxter Healthcare Pty Ltd
Medicine Registered
BAXTER IRINOTECAN (irinotecan hydrochloride) Consumer Medicine Information BAXTER IRINOTECAN CMI 090107 Page 1 of 5 Baxter BAXTER IRINOTECAN _Irinotecan hydrochloride _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Irinotecan hydrochloride concentrated injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Irinotecan hydrochloride concentrated injection against the benefits they expect it will have for you. ASK YOUR DOCTOR IF YOU HAVE ANY CONCERNS ABOUT BEING TREATED WITH THIS MEDICINE. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT IRINOTECAN HYDROCHLORIDE CONCENTRATED INJECTION IS USED FOR Irinotecan hydrochloride concentrated injection is used to treat bowel cancer which has spread to other parts of the body. Cancer which has spread cannot be treated by surgery alone and one of the options in this situation is treatment with an anticancer medicine, known as chemotherapy. Alternatively, Irinotecan hydrochloride concentrated injection is used alone when the cancer has not responded or has returned after initial treatment. Irinotecan hydrochloride concentrated injection is specially developed to target cancer cells rather than normal, healthy cells. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IRINOTECAN HYDROCHLORIDE CONCENTRATED INJECTION HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed Irinotecan hydrochloride concentrated injection for another purpose. Irinotecan hydrochloride concentrated injection is not addictive. This medicine is available only with a doctor Lees het volledige document
1 PRODUCT INFORMATION BAXTER IRINOTECAN HYDROCHLORIDE CONCENTRATED INJECTION NAME OF THE MEDICINE: Non-proprietary name: Irinotecan hydrochloride concentrated injection Chemical name: (4_S_)-4, 11-diethyl-4-hydroxy-9-[(4- piperidinopiperidino)carbonyloxy]-1_H_-pyrano[3', 4':6, 7]indolizino[1, 2- _b_]quinoline-3, 14(4_H_, 12_H_)dione hydrochloride trihydrate CAS Number: CAS-136572-09-3 Irinotecan hydrochloride is a pale yellow to yellow crystalline powder, with the empirical formula C 33 H 38 N 4 O 6 •HCl•3H 2 O and a molecular weight of 677.19. Irinotecan hydrochloride is slightly soluble in water and organic solvents. DESCRIPTION: Irinotecan hydrochloride is an antineoplastic agent of the topoisomerase I inhibitor class. Irinotecan hydrochloride is a semisynthetic derivative of camptothecin, an alkaloid extract from plants such as _Camptotheca acuminata._ Irinotecan hydrochloride concentrated injection is supplied as a sterile, pale yellow, clear, aqueous solution of pH 3.5. It is intended for dilution with 5% Glucose Injection (_preferred_) or 0.9% Sodium Chloride Injection prior to infusion. In addition to irinotecan hydrochloride, the ingredients are sorbitol, lactic acid, sodium hydroxide and water for injections. 2 PHARMACOLOGY: Irinotecan hydrochloride is a derivative of camptothecin. Camptothecins interact specifically with the enzyme topoisomerase I which relieves torsional strain in DNA by inducing reversible single-strand breaks. Irinotecan hydrochloride and its active metabolite SN-38 bind to the topoisomerase I - DNA complex and prevent religation of these single-strand breaks. Current research suggests that the cytotoxicity of irinotecan hydrochloride is due to double-strand DNA damage produced during DNA synthesis when replicati Lees het volledige document